best peptides for endurance FAQ

Integrate MOTS-C at 5mg twice weekly throughout your base-building phase and add BPC-157 at 250mcg daily during peak mileage weeks. MOTS-C increases mitochondrial efficiency so your muscles produce more ATP per oxygen molecule. Delaying the shift to glycolytic metabolism that signals fatigue. BPC-157 reduces the inflammatory response to microtrauma in connective tissues, allowing you to recover between high-volume sessions without accumulating tendinopathy risk. The combination doesn't prevent overtraining, but it extends the training load ceiling before breakdown occurs.

Add TB-500 at 5mg twice weekly for 12 weeks. The plateau likely reflects vascular limitations rather than cardiorespiratory constraints. If your VO2 max hasn't increased but your power at lactate threshold remains stagnant, capillary density may be the limiting factor. TB-500 increases capillary-to-fiber ratio, improving oxygen diffusion from blood to mitochondria. Expect measurable improvements in sustained power output after 8–10 weeks, not within single training blocks.

Use BPC-157 at 500mcg daily injected subcutaneously near the Achilles insertion point, combined with eccentric calf loading protocols three times weekly. BPC-157 accelerates collagen remodeling, but remodeling requires mechanical stimulus. The peptide works synergistically with rehab exercises, not as a replacement. Most athletes see functional improvement (reduced pain during running) within 2–3 weeks, but full structural healing requires 8–12 weeks of consistent dosing and progressive loading.

Thymosin Beta-4 (TB-500) is primarily studied for tissue repair and angiogenesis (new blood vessel formation), not aerobic performance. While increased capillary density theoretically improves oxygen delivery to muscle, no controlled human trials have measured endurance outcomes with TB-500. Anecdotal reports in athletic forums describe faster recovery from overuse injuries, but that's not the same mechanism as mitochondrial biogenesis or erythropoiesis. If your goal is endurance performance rather than injury recovery, MOTS-c or SS-31 have stronger mechanistic rationale.

MOTS-c offers the most applicable endurance benefit for aerobic-base training phases because it amplifies mitochondrial adaptation in response to high-volume, low-intensity work. Dose 10mg subcutaneously twice weekly during build phases when weekly mileage is highest. The compound won't replace long runs or tempo sessions. It increases the magnitude of adaptation you get from the same training stimulus. EPO analogs produce larger acute performance gains but require medical supervision due to thrombotic risk and carry legal consequences in competitive contexts.

Combine Ipamorelin (150mcg) with CJC-1295 (150mcg) subcutaneously before bed on training days. This raises endogenous GH release without suppressing natural pulsatile patterns. Expect noticeable reductions in muscle soreness and faster creatine kinase clearance within 10–14 days. Don't expect faster race times from the peptide alone. The benefit is tolerance for higher training loads, which generates performance gains over 8–12 weeks through accumulated volume.

Unreconstituted lyophilized peptides tolerate short-term temperature excursions better than pre-mixed solutions. MOTS-c and Ipamorelin powders remain stable at room temperature for 48–72 hours, though long-term storage requires freezing at −20°C. Once reconstituted, all peptides must stay between 2–8°C. A portable insulin cooler with ice packs maintains this range for 36–48 hours without electricity. If a vial reaches ambient temperature for more than 6 hours, assume potency loss of 15–30% and adjust dosing upward or discard.